Publication
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
Scientific Reports 9(1):9046, 2019
Roth JD, Veidal SS, Fensholdt LKD, Rigbolt KTG, Papazyan R, Nielsen JC, Feigh M, Vrang N, Young M, Jelsing J, Adorini L, Hansen HH
Therapeutic AreaMouseTargetCompoundMethod/EndpointSpeciesBody compositionBody weightAMLN ob/ob-NASH (AMLN ob/ob-MASH) mouseBioinformaticsNon-alcoholic steatohepatitis/Metabolic dysfunction-associated steatohepatitis (NASH/MASH)FXRElafibranorHistopathology scoreImage analysisImmunohistochemistryLiver biopsyLiver morphometryPPARRNA sequencingObeticholic acid
Share this page
Related resources
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650